Syed Saad Mahmood, MD🫀 (@saadmahmoodmd) 's Twitter Profile
Syed Saad Mahmood, MD🫀

@saadmahmoodmd

Cardiologist / CadioOncologist. System-Director #CardioOnc at @StFrancis_LI @CHS_LI

ID: 3239097700

linkhttps://www.linkedin.com/in/ssmahmood calendar_today06-05-2015 16:01:13

1,1K Tweet

1,1K Takipçi

399 Takip Edilen

Syed Saad Mahmood, MD🫀 (@saadmahmoodmd) 's Twitter Profile Photo

🚨 St Francis Heart Center, NY #CardioOnc Journal Club 📖 with OPCI . Daniel Addison, MD (Ohio State University) joins us to discuss CV events associated with Bispecific antibody therapy for cancer 🦠. Watch episode: opci.live/opci-lives/car… St. Francis Hospital & Heart Center Catholic Health

🚨 St Francis Heart Center, NY #CardioOnc Journal Club 📖 with <a href="/OPCILive/">OPCI</a> .

<a href="/md_addison/">Daniel Addison, MD</a> (Ohio State University) joins us to discuss CV events associated with Bispecific antibody therapy for cancer 🦠.

Watch episode: opci.live/opci-lives/car…

<a href="/StFrancis_LI/">St. Francis Hospital & Heart Center</a> <a href="/CHS_LI/">Catholic Health</a>
Jaffar Khan (@cathelectrosurg) 's Twitter Profile Photo

Structural Clinical Research Fellowship at St Francis Hospital, NY, now accepting applicants! Join one of the highest volume, most innovative and friendly structural heart centers in the world. For post-interventional fellows. Deadline Sep 30th. opci.events/structuralfell…

Structural Clinical Research Fellowship at St Francis Hospital, NY, now accepting applicants!

Join one of the highest volume, most innovative and friendly structural heart centers in the world. 

For post-interventional fellows. Deadline Sep 30th. 

opci.events/structuralfell…
Ziad Ali (@ziadalinyc) 's Twitter Profile Photo

This is an incredible opportunity! Our research fellows are publishing in the double digits with high impact papers. The output combined with the chance to work with Jaffar Khan Omar Khalique and David J. Cohen, MD, MSc as mentors is a 1-of-a-kind fellowship.

Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 (@pabeda1) 's Twitter Profile Photo

A study by Nick Nurmohamed Dr Andrew D. Choi Pradeep Natarajan et al: The 1st prosperctive FU so far, showing that among people undergoing 2 CCTA's 10 years apart, those w/a high genome-wide #polygenicriskscore have a 6-fold chance of developing high risk plaques, among other findings!

A  study by <a href="/NickNurmohamed/">Nick Nurmohamed</a> <a href="/AChoiHeart/">Dr Andrew D. Choi</a> <a href="/pnatarajanmd/">Pradeep Natarajan</a> et al: The 1st prosperctive FU so far, showing that among people undergoing 2  CCTA's 10 years apart, those w/a high genome-wide #polygenicriskscore have a 6-fold chance of developing high risk plaques, among other findings!
Harlan Krumholz (@hmkyale) 's Twitter Profile Photo

Kudos to our authors at #ESCCongress! 67 pubs across 9 JACC Journals: •50 in JACC (6 Hotlines, 12 Late Breaking Science) •4 in JACC Adv •3 in JACC Imag & HF •2 in JACC Int & CardioOnc •1 in JACC BTS, EP & Case Rep #ESC2024 American College of Cardiology   jacc.org/events/confere…

Syed Saad Mahmood, MD🫀 (@saadmahmoodmd) 's Twitter Profile Photo

Landed in London for #ESCCongress2024 European Society of Cardiology . Nice to be visiting again, and always appreciate the complimentary luggage carts in 🇬🇧 airports. Tad different from 🇺🇸

Landed in London for #ESCCongress2024 <a href="/escardio/">European Society of Cardiology</a> .

Nice to be visiting again, and always appreciate the complimentary luggage carts in 🇬🇧 airports. Tad different from 🇺🇸
Syed Saad Mahmood, MD🫀 (@saadmahmoodmd) 's Twitter Profile Photo

Using UK Biobank, investigating performance of a heart failure polygenic risk score vs conventional risk factors to predict heart failure among cancer survivors. #CardioOnc #ESCCongress2024 jacc.org/doi/epdf/10.10…

Using UK Biobank, investigating performance of a heart failure polygenic risk score vs conventional risk factors to predict heart failure among cancer survivors.

#CardioOnc #ESCCongress2024 

jacc.org/doi/epdf/10.10…
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

The SENIOR-RITA trial found that an invasive strategy involving coronary revascularization plus medical therapy did not significantly reduce the risk of cardiovascular death or nonfatal myocardial infarction compared to a conservative medical therapy approach in older patients

The SENIOR-RITA trial found that an invasive strategy involving coronary revascularization plus medical therapy did not significantly reduce the risk of cardiovascular death or nonfatal myocardial infarction compared to a conservative medical therapy approach in older patients
International Cardio-Oncology Society (@icosociety) 's Twitter Profile Photo

Thank you to everyone who came out to our joint dinner with European Society of Cardiology this past Friday in London! We look forward to seeing everyone again soon at #GCOS24 #cardionc #cardiology

Thank you to everyone who came out to our joint dinner with <a href="/escardio/">European Society of Cardiology</a> this past Friday in London! We look forward to seeing everyone again soon at #GCOS24

#cardionc #cardiology
Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile Photo

Only a matter of time! Now in NEJM: Rapid remission in refractory lupus with teclistamab (BCMA bsAb) x5 wks, including 3rd SUD. Authors astutely note that CD19 CARs also work here... sounds like the #lymsm and #MMsm fields will compete for which of our fields cures lupus 1st!

Only a matter of time! Now in <a href="/NEJM/">NEJM</a>: Rapid remission in refractory lupus with teclistamab (BCMA bsAb) x5 wks, including 3rd SUD.

Authors astutely note that CD19 CARs also work here... sounds like the #lymsm and #MMsm fields will compete for which of our fields cures lupus 1st!
Syed Saad Mahmood, MD🫀 (@saadmahmoodmd) 's Twitter Profile Photo

Big advance in our understanding of cancer related cachexia - treated with antibody against GDF-15. Congrats to Dr John Groarke et al - a terrific colleague and collaborator from #CardioOnc fellowship . Pfizer Inc. nejm.org/doi/full/10.10…